{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:43:13Z","timestamp":1790743393372,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008798","name":"Ministry of Science Research and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008798","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ijbiomac.2020.05.225","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T10:09:15Z","timestamp":1590833355000},"page":"1029-1041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Targeted anticancer prodrug therapy using dextran mediated enzyme\u2013antibody conjugate and \u03b2-cyclodextrin-curcumin inclusion complex"],"prefix":"10.1016","volume":"160","author":[{"given":"Sahar","family":"Roozbehi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Dadashzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manouchehr","family":"Mirshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Sadeghizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza H.","family":"Sajedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0005","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0010","first-page":"14","article-title":"Monoclonal antibodies in cancer therapy","volume":"12","author":"Scott","year":"2012","journal-title":"Cancer Immun. Arch."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ijbiomac.2019.12.064","article-title":"Enzyme immobilization onto the nanomaterials: application in enzyme stability and prodrug-activated cancer therapy","volume":"143","author":"Sharifi","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0020","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0952-7915(99)00012-6","article-title":"Monoclonal antibody drug conjugates in the treatment of cancer","volume":"11","author":"Trail","year":"1999","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0025","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1517\/14712598.4.11.1777","article-title":"Antibody-directed enzyme prodrug therapy (ADEPT) for cancer","volume":"4","author":"Bagshawe","year":"2004","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0030","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/CJI.0b013e318234ecf5","article-title":"Targeted drug delivery using immunoconjugates: principles and applications","volume":"34","author":"Pasquetto","year":"2011","journal-title":"J. Immunother."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0035","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1517\/14712598.2016.1173203","article-title":"Prospects and progress of antibody-drug conjugates in solid tumor therapies","volume":"16","author":"Govindan","year":"2016","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0040","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nbt0505-556","article-title":"Tunable antibodies","volume":"23","author":"Weiner","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2017.09.009","article-title":"Antibody Directed Enzyme Prodrug Therapy (ADEPT): trials and tribulations","volume":"118","author":"Sharma","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0050","first-page":"233","article-title":"Antibody Directed Enzyme Prodrug Therapy (ADEPT): a promising cancer therapy approach","author":"Amly","year":"2014","journal-title":"PRODRUGS Des"},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0055","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3892\/ijo.9.3.567","article-title":"Antibody-directed enzyme prodrug therapy (ADEPT)","volume":"9","author":"Retta","year":"1996","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0060","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/sj.bjc.6690221","article-title":"Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug","volume":"79","author":"Cheng","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1208\/s12248-014-9675-7","article-title":"Gene-directed enzyme prodrug therapy","volume":"17","author":"Zhang","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0169-409X(01)00206-X","article-title":"Selective activation of anticancer prodrugs by monoclonal antibody\u2013enzyme conjugates","volume":"53","author":"Senter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0075","series-title":"Macromol. Anticancer Ther","first-page":"393","article-title":"Antibody-directed enzyme prodrug therapy (ADEPT) for cancer","author":"Sharma","year":"2010"},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0080","doi-asserted-by":"crossref","first-page":"10940","DOI":"10.1021\/cr500081p","article-title":"Review: a history of cyclodextrins","volume":"114","author":"Crini","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0085","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/jps.23077","article-title":"Cyclodextrins as functional excipients: methods to enhance complexation efficiency","volume":"101","author":"Loftsson","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0090","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00396-013-3124-5","article-title":"Inclusion complexes of rosmarinic acid and cyclodextrins: stoichiometry, association constants, and antioxidant potential","volume":"292","author":"Medronho","year":"2014","journal-title":"Colloid Polym. Sci."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2012.06.055","article-title":"Cyclodextrins","volume":"453","author":"Kurkov","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0100","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cis.2013.08.001","article-title":"The formation of host-guest complexes between surfactants and cyclodextrins","volume":"205","author":"Valente","year":"2014","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2013.04.063","article-title":"Substrate preference of a Geobacillus maltogenic amylase: a kinetic and thermodynamic analysis","volume":"60","author":"Nasrollahi","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0110","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2478\/s11756-008-0171-3","article-title":"Differences and similarities in enzymes from the neopullulanase subfamily isolated from thermophilic species","volume":"63","author":"Nordberg Karlsson","year":"2008","journal-title":"Biologia (Bratisl)"},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/nrclinonc.2011.177","article-title":"Treatment of HER2-positive breast cancer: current status and future perspectives","volume":"9","author":"Arteaga","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0120","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0125","first-page":"350","article-title":"Trastuzumab emtansine, an antibody-drug conjugate for the treatment of HER2+ metastatic breast cancer","volume":"12","author":"Niculescu-Duvaz","year":"2010","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0130","first-page":"2825","article-title":"Recombinant humanized anti-HER2 antibody (HerceptinTM) enhances the antitumor activity of paclitaxel and doxorubicin against HER2\/neu overexpressing human breast cancer xenografts","volume":"58","author":"Baselga","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0135","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/jnci\/djh131","article-title":"Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer","volume":"96","author":"Pegram","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-2867-14-10","article-title":"Correlation between HER-2\/neu (erbB-2) expression level and therapeutic effect of combination treatment with HERCEPTIN and chemotherapeutic agents in gastric cancer cell lines","volume":"14","author":"Cui","year":"2014","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0145","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMoa1209124","article-title":"Trastuzumab emtansine for HER2-positive advanced breast cancer","volume":"367","author":"Verma","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0150","series-title":"A Phase I Expansion Cohorts Study of SYD985 in Heavily Pretreated Patients With HER2-positive or HER2-low Metastatic Breast Cancer","author":"Saura","year":"2018"},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0155","series-title":"Trastuzumab Deruxtecan (DS-8201a) in Subjects With HER2-expressing Solid Tumors: Long-term Results of a Large Phase 1 Study With Multiple Expansion Cohorts","author":"Iwata","year":"2018"},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0160","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/17425247.2012.673580","article-title":"Dextran conjugates in drug delivery","volume":"9","author":"Varshosaz","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0165","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ijbiomac.2020.01.206","article-title":"Antioxidant, antibacterial and anti-cancer activities of \u03b2-and \u03b3-CDs\/curcumin loaded in chitosan nanoparticles","volume":"147","author":"Alizadeh","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110726","article-title":"Encapsulating curcumin in ethylene diamine-\u03b2-cyclodextrin nanoparticle improves topical cornea delivery","volume":"186","author":"Liu","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0175","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.colsurfb.2010.03.039","article-title":"\u03b2-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells","volume":"79","author":"Yallapu","year":"2010","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0180","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1021\/ac60147a030","article-title":"Use of dinitrosalicylic acid reagent for determination of reducing sugar","volume":"31","author":"Release","year":"1959","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0185","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1007\/s00604-017-2527-2","article-title":"A dextran mediated multicolor immunochromatographic rapid test strip for visual and instrumental simultaneous detection of Vibrio cholera O1 (Ogawa) and Clostridium botulinum toxin A","volume":"184","author":"Gharaat","year":"2017","journal-title":"Microchim. Acta"},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/bab.58","article-title":"Synthesis of a unique high-performance poly-horseradish peroxidase complex to enhance sensitivity of immunodetection systems","volume":"59","author":"Charbgoo","year":"2012","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0195","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1749-6632.1964.tb14213.x","article-title":"Disc electrophoresis. II. Method and application to human serum proteins","volume":"121","author":"Davis","year":"1964","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0200","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1134\/S1990519X09020096","article-title":"Acridine orange distribution and fluorescence spectra in myoblasts and single muscle fibers","volume":"3","author":"Belyaeva","year":"2009","journal-title":"Cell Tissue Biol"},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0205","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/j150613a012","article-title":"Fluorescence enhancement of benzene derivatives by forming inclusion complexes with. beta.-cyclodextrin in aqueous solutions","volume":"85","author":"Hoshino","year":"1981","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.molliq.2010.11.004","article-title":"Fluorescence enhancement of rhodamine 6G by forming inclusion complexes with \u03b2-cyclodextrin","volume":"158","author":"Bakkialakshmi","year":"2011","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0215","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12913-015-1018-6","article-title":"Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests","volume":"15","author":"Vyberg","year":"2015","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0220","series-title":"Production of rabbit monoclonal antibodies against mouse embryonic stem cells and identification of pluripotency\u2014associated surface antigens","first-page":"149","volume":"365","author":"Tan","year":"2011"},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1369\/jhc.6A7017.2006","article-title":"Direct detection of herceptin\/trastuzumab binding on breast tissue sections","volume":"55","author":"Glazyrin","year":"2007","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0230","series-title":"A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections","first-page":"1","author":"Nitta","year":"2012"},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0235","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/aps.2012.34","article-title":"Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells","volume":"33","author":"Punfa","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0240","doi-asserted-by":"crossref","first-page":"107374","DOI":"10.18632\/oncotarget.22376","article-title":"Folic acid conjugation improves the bioavailability and chemosensitizing efficacy of curcumin-encapsulated PLGA-PEG nanoparticles towards paclitaxel chemotherapy","volume":"8","author":"Thulasidasan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0245","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.apsusc.2015.09.189","article-title":"Targeted delivery and pH-responsive release of stereoisomeric anti-cancer drugs using \u03b2-cyclodextrin assemblied Fe3O4nanoparticles","volume":"357","author":"Wang","year":"2015","journal-title":"Appl. Surf. Sci."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0250","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1248\/cpb.c13-00950","article-title":"Synthesis and inclusion study of a novel \u03b3-cyclodextrin derivative as a potential thermo-sensitive carrier for doxorubicin","volume":"62","author":"Xu","year":"2014","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0255","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1039\/b816209c","article-title":"Cyclodextrin-covered gold nanoparticles for targeted delivery of an anti-cancer drug","volume":"19","author":"Park","year":"2009","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms4702","article-title":"Poly-cyclodextrin and poly-paclitaxel nano-assembly for anticancer therapy","volume":"5","author":"Namgung","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0265","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijbiomac.2019.02.129","article-title":"Aptamer functionalized curcumin-loaded human serum albumin (HSA) nanoparticles for targeted delivery to HER-2 positive breast cancer cells","volume":"130","author":"Saleh","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0270","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10549-013-2667-y","article-title":"Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells","volume":"141","author":"Catania","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0275","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s11064-007-9376-z","article-title":"Curcumin suppressed anti-apoptotic signals and activated cysteine proteases for apoptosis in human malignant glioblastoma U87MG cells","volume":"32","author":"Karmakar","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0280","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2006.08.013","article-title":"Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells","volume":"407","author":"Karmakar","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddis.2013.26","article-title":"Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil","volume":"4","author":"Vinod","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0290","first-page":"394","article-title":"Cyclodextrin complexes: an approach to improve the physicochemical properties of drugs and applications of cyclodextrin complexes","volume":"12","author":"Vikas","year":"2018","journal-title":"Asian J. Pharm. Free Full Text Artic. from Asian J Pharm."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0295","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1002\/jps.22033","article-title":"The solubility\u2013permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone","volume":"99","author":"Dahan","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2020.05.225_bb0300","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.2042-7158.2011.01279.x","article-title":"Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes","volume":"63","author":"Loftsson","year":"2011","journal-title":"J. Pharm. Pharmacol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020333821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020333821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T20:46:39Z","timestamp":1750884399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813020333821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":60,"alternative-id":["S0141813020333821"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.05.225","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted anticancer prodrug therapy using dextran mediated enzyme\u2013antibody conjugate and \u03b2-cyclodextrin-curcumin inclusion complex","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.05.225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}